More tools:Markets·Screener·Research·Chat

CONMED Corporation (CNMD) Financial Statements

CONMED Corporation
SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
FIGI BBG001S5PZH2
XNYS · usd
46.69▲ 0.10 (0.21%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close46.59
Day's Range45.91 – 49.09
52-Week Range31.44 – 54.81
Volume329.7K
Avg Volume411.6K
Share Statistics
Shares Outstanding
Employees3,900
ExchangeXNYS
Listed1987-07-23
Share count as of July 27, 2026
Loading Income Statement…
Key questions about CONMED Corporation (CNMD)
What is CONMED Corporation's Market Cap?
CONMED Corporation's Market Cap is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Enterprise Value?
CONMED Corporation's Enterprise Value is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Trailing P/E?
CONMED Corporation's Trailing P/E is 24.8×, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Price / Sales?
CONMED Corporation's Price / Sales is 1.0×, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's EV / Revenue?
CONMED Corporation's EV / Revenue is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's EV / EBITDA?
CONMED Corporation's EV / EBITDA is 13.5×, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Revenue (TTM)?
CONMED Corporation's Revenue (TTM) is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Net Income (TTM)?
CONMED Corporation's Net Income (TTM) is $56.5M, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's EBITDA?
CONMED Corporation's EBITDA is $162.4M, based on as-reported figures from SEC (XBRL) filings.
What is CONMED Corporation's Diluted EPS (TTM)?
CONMED Corporation's Diluted EPS (TTM) is 1.89, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net sales—
YoY growth+0.3%—+7.9%+6.7%
Cost of sales—
Gross profit—
% of revenue57.5%—58.5%49.2%
Selling and administrative expense—
Research and development expense—
Operating expenses—
% of revenue46.9%—48.7%45.6%
Income from operations—
% of revenue10.6%—9.8%3.5%
Interest expense—
Other (income) / expense———
Income before income taxes—
Provision for income taxes—
Net income
% of revenue6.7%—4.5%0.8%
Basic (in dollars per share)——
Diluted (in dollars per share)——